Close
Back to PTGX Stock Lookup

Protagonist Therapeutics (PTGX) – Analyst EPS Change

Jul 30, 2021 10:13 AM UPDATE: Protagonist Therapeutics (PTGX) PT Raised to $93 at Piper Sandler on PN-943 Increasing Likelihood of Success
Nov 8, 2019 06:44 AM Nomura/Instinet Reiterates Buy Rating on Protagonist Therapeutics (PTGX), Expects Upside in PTG-300 Results

Back to PTGX Stock Lookup